Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1966 1
2000 3
2001 1
2002 1
2006 2
2008 1
2010 1
2011 2
2012 2
2014 5
2015 4
2016 3
2018 2
2019 4
2020 4
2021 5
2022 2
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Berdeja JG, Madduri D, Usmani SZ, Jakubowiak A, Agha M, Cohen AD, Stewart AK, Hari P, Htut M, Lesokhin A, Deol A, Munshi NC, O'Donnell E, Avigan D, Singh I, Zudaire E, Yeh TM, Allred AJ, Olyslager Y, Banerjee A, Jackson CC, Goldberg JD, Schecter JM, Deraedt W, Zhuang SH, Infante J, Geng D, Wu X, Carrasco-Alfonso MJ, Akram M, Hossain F, Rizvi S, Fan F, Lin Y, Martin T, Jagannath S. Berdeja JG, et al. Among authors: allred aj. Lancet. 2021 Jul 24;398(10297):314-324. doi: 10.1016/S0140-6736(21)00933-8. Epub 2021 Jun 24. Lancet. 2021. PMID: 34175021 Clinical Trial.
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Martin T, Usmani SZ, Berdeja JG, Agha M, Cohen AD, Hari P, Avigan D, Deol A, Htut M, Lesokhin A, Munshi NC, O'Donnell E, Stewart AK, Schecter JM, Goldberg JD, Jackson CC, Yeh TM, Banerjee A, Allred A, Zudaire E, Deraedt W, Olyslager Y, Zhou C, Pacaud L, Madduri D, Jakubowiak A, Lin Y, Jagannath S. Martin T, et al. Among authors: allred a. J Clin Oncol. 2023 Feb 20;41(6):1265-1274. doi: 10.1200/JCO.22.00842. Epub 2022 Jun 4. J Clin Oncol. 2023. PMID: 35658469 Free PMC article.
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, Kudchadkar R, Burris HA 3rd, Falchook G, Algazi A, Lewis K, Long GV, Puzanov I, Lebowitz P, Singh A, Little S, Sun P, Allred A, Ouellet D, Kim KB, Patel K, Weber J. Flaherty KT, et al. Among authors: allred a. N Engl J Med. 2012 Nov 1;367(18):1694-703. doi: 10.1056/NEJMoa1210093. Epub 2012 Sep 29. N Engl J Med. 2012. PMID: 23020132 Free PMC article. Clinical Trial.
Pathways of angiotensin-(1-7) metabolism in the kidney.
Chappell MC, Allred AJ, Ferrario CM. Chappell MC, et al. Among authors: allred aj. Nephrol Dial Transplant. 2001;16 Suppl 1:22-6. doi: 10.1093/ndt/16.suppl_1.22. Nephrol Dial Transplant. 2001. PMID: 11369816 Review.
A Targeted Sequencing Assay for Serotyping Escherichia coli Using AgriSeq Technology.
Elder JR, Fratamico PM, Liu Y, Needleman DS, Bagi L, Tebbs R, Allred A, Siddavatam P, Suren H, Gujjula KR, DebRoy C, Dudley EG, Yan X. Elder JR, et al. Among authors: allred a. Front Microbiol. 2021 Jan 15;11:627997. doi: 10.3389/fmicb.2020.627997. eCollection 2020. Front Microbiol. 2021. PMID: 33519788 Free PMC article.
Saving Lives: Suicide Prevention in LGBTQ Youth.
Allred A, Allred K. Allred A, et al. J Psychosoc Nurs Ment Health Serv. 2024 Apr;62(4):6-8. doi: 10.3928/02793695-20240307-01. Epub 2024 Apr 1. J Psychosoc Nurs Ment Health Serv. 2024. PMID: 38569095
47 results